David García-Solís

822 total citations
26 papers, 605 citations indexed

About

David García-Solís is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, David García-Solís has authored 26 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Physiology and 7 papers in Psychiatry and Mental health. Recurrent topics in David García-Solís's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (9 papers) and Alzheimer's disease research and treatments (7 papers). David García-Solís is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (9 papers) and Alzheimer's disease research and treatments (7 papers). David García-Solís collaborates with scholars based in Spain, Sweden and France. David García-Solís's co-authors include Pablo Mir, Francisco Javier García Gómez, F. Carrillo, Silvia Jesús, Ildefonso Espigado, A Gil-Peralta, Aurelio Cayuela, Francisco Moniche, Antonio Mayol and Pilar Piñero and has published in prestigious journals such as PLoS ONE, NeuroImage and Stroke.

In The Last Decade

David García-Solís

24 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David García-Solís Spain 12 246 120 106 106 101 26 605
Sook Keun Song South Korea 13 412 1.7× 105 0.9× 83 0.8× 117 1.1× 159 1.6× 27 661
James J. P. Alix United Kingdom 16 273 1.1× 161 1.3× 99 0.9× 110 1.0× 183 1.8× 55 819
Kazutaka Sugimoto Japan 16 189 0.8× 81 0.7× 75 0.7× 74 0.7× 129 1.3× 48 695
Arlete Hilbig Brazil 14 258 1.0× 90 0.8× 79 0.7× 52 0.5× 191 1.9× 45 736
Katsufumi Kajimoto Japan 14 123 0.5× 60 0.5× 95 0.9× 91 0.9× 37 0.4× 40 585
Anna Micheli Italy 11 324 1.3× 99 0.8× 105 1.0× 210 2.0× 67 0.7× 13 540
Luca Maderna Italy 13 345 1.4× 115 1.0× 78 0.7× 91 0.9× 94 0.9× 31 681
Margaret A. Parsley United States 14 372 1.5× 88 0.7× 35 0.3× 87 0.8× 103 1.0× 22 739
Franco Chioffi Italy 18 248 1.0× 160 1.3× 268 2.5× 95 0.9× 82 0.8× 42 929

Countries citing papers authored by David García-Solís

Since Specialization
Citations

This map shows the geographic impact of David García-Solís's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David García-Solís with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David García-Solís more than expected).

Fields of papers citing papers by David García-Solís

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David García-Solís. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David García-Solís. The network helps show where David García-Solís may publish in the future.

Co-authorship network of co-authors of David García-Solís

This figure shows the co-authorship network connecting the top 25 collaborators of David García-Solís. A scholar is included among the top collaborators of David García-Solís based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David García-Solís. David García-Solís is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García-Solís, David, et al.. (2025). TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers. Journal of Alzheimer s Disease. 105(1). 65–76.
2.
Silva‐Rodríguez, Jesús, Miguel A. Labrador‐Espinosa, Laura Muñoz‐Delgado, et al.. (2025). Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2002–2014. 2 indexed citations
3.
Franco‐Macías, Emilio, et al.. (2025). Evaluation of early-phase 18 F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with 18 F-FDG PET at group and single patient level. Journal of Alzheimer s Disease. 106(1). 304–316. 1 indexed citations
4.
Silva‐Rodríguez, Jesús, Miguel A. Labrador‐Espinosa, Laura Muñoz‐Delgado, et al.. (2024). The effect of AD co‐pathology on cognitive phenotype and FDG‐PET patterns in Parkinson’s disease with cognitive impairment. Alzheimer s & Dementia. 20(S2). 1 indexed citations
5.
Sánchez‐Arjona, María Bernal, et al.. (2023). Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease. Journal of Alzheimer s Disease. 97(1). 447–458.
6.
García-Solís, David, et al.. (2020). Differential diagnosis of HaNDL syndrome in a case report of a pediatric patient: The role of SPECT with 99mTc-HMPAO. eNeurologicalSci. 19. 100240–100240. 1 indexed citations
7.
Camacho, Valle, Adolfo Gómez‐Grande, David García-Solís, et al.. (2018). PET amiloide en enfermedades neurodegenerativas que cursan con demencia. Revista Española de Medicina Nuclear e Imagen Molecular. 37(6). 397–406. 3 indexed citations
8.
Oldehinkel, Marianne, et al.. (2017). A Bayesian spatial model for neuroimaging data based on biologically informed basis functions. NeuroImage. 161. 134–148. 14 indexed citations
9.
Jesús, Silvia, Francisco Javier García Gómez, María Teresa Cáceres‐Redondo, et al.. (2017). Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype. PLoS ONE. 12(3). e0174644–e0174644. 23 indexed citations
10.
Jesús, Silvia, Francisco Javier García Gómez, Inmaculada Bernal‐Bernal, et al.. (2017). Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease. PLoS ONE. 12(4). e0175560–e0175560. 26 indexed citations
11.
Huertas‐Fernández, Ismael, Francisco Javier García Gómez, David García-Solís, et al.. (2014). Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123I]FP-CIT SPECT. European Journal of Nuclear Medicine and Molecular Imaging. 42(1). 112–119. 43 indexed citations
12.
González‐Escamilla, Gabriel, Mercedes Atienza, David García-Solís, & José L. Cantero. (2014). Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment. Brain Structure and Function. 221(1). 631–645. 20 indexed citations
13.
Arbizu, Javier, M. R. Luquín, Raúl de la Fuente‐Fernández, et al.. (2014). Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: actualización y recomendaciones para el uso clínico. Revista Española de Medicina Nuclear e Imagen Molecular. 33(4). 215–226. 11 indexed citations
14.
Suárez‐González, Aida, Alberto Serrano‐Pozo, Eva M. Arroyo-Anlló, et al.. (2013). Utility of neuropsychiatric tools in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease: quantitative and qualitative findings. International Psychogeriatrics. 26(3). 453–461. 18 indexed citations
15.
Gómez, Francisco Javier García, et al.. (2013). Elaboración de una plantilla de SPM para la normalización de imágenes de SPECT con 123I-Ioflupano. Revista Española de Medicina Nuclear e Imagen Molecular. 32(6). 350–356. 38 indexed citations
16.
García-Solís, David, Ismael Huertas‐Fernández, Francisco Javier García Gómez, et al.. (2012). Clinical features and123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 84(2). 122–129. 57 indexed citations
17.
Moniche, Francisco, Alejandro González, Magdalena Carmona, et al.. (2012). Intra-Arterial Bone Marrow Mononuclear Cells in Ischemic Stroke. Stroke. 43(8). 2242–2244. 168 indexed citations
18.
Cantero, José L., et al.. (2009). Functional integrity of thalamocortical circuits differentiates normal aging from mild cognitive impairment. Human Brain Mapping. 30(12). 3944–3957. 42 indexed citations
19.
Diaz‐Corrales, Francisco J., et al.. (2009). Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 37(3). 556–564. 41 indexed citations
20.
Martín-Comín, J., et al.. (2000). Practice of nuclear medicine in Spain. European Journal of Nuclear Medicine and Molecular Imaging. 28(1). 105–112. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sook Keun Song Breakdown of academic impact, for papers by James J. P. Alix Breakdown of academic impact, for papers by Kazutaka Sugimoto Breakdown of academic impact, for papers by Arlete Hilbig Breakdown of academic impact, for papers by Katsufumi Kajimoto Breakdown of academic impact, for papers by Anna Micheli Breakdown of academic impact, for papers by Luca Maderna Breakdown of academic impact, for papers by Margaret A. Parsley Breakdown of academic impact, for papers by Franco Chioffi
Rankless by CCL
2026